<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Commun</journal-id><journal-id journal-id-type="iso-abbrev">Brain Commun</journal-id><journal-id journal-id-type="publisher-id">braincomms</journal-id><journal-title-group><journal-title>Brain Communications</journal-title></journal-title-group><issn pub-type="epub">2632-1297</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38116142</article-id><article-id pub-id-type="pmc">PMC10729846</article-id><article-id pub-id-type="doi">10.1093/braincomms/fcad340</article-id><article-id pub-id-type="publisher-id">fcad340</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00310</subject><subject>AcademicSubjects/SCI01870</subject></subj-group></article-categories><title-group><article-title>Limbic system damage following SARS-CoV2 infection</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Taskiran-Sag</surname><given-names>Aslihan</given-names></name><aff>
<institution>Department of Neurology, Faculty of Medicine, TOBB University of Economics and Technology</institution>, <addr-line>06510, Ankara</addr-line>, <country country="TR">Turkey</country></aff><xref rid="fcad340-cor1" ref-type="corresp"/><!--aslihantaskiran@gmail.com--></contrib><contrib contrib-type="author"><name><surname>Yazgi</surname><given-names>Hare</given-names></name><aff>
<institution>Faculty of Medicine, TOBB University of Economics and Technology</institution>, <addr-line>06510 Ankara</addr-line>, <country country="TR">Turkey</country></aff></contrib></contrib-group><author-notes><corresp id="fcad340-cor1">Correspondence to: Aslihan Taskiran-Sag Department of Neurology, Faculty of Medicine, TOBB University of Economics and Technology, Be&#x0015f;tepe, Ya&#x0015f;am Cd. No:5, 06560 Yenimahalle/Ankara, Turkey E-mail: <email>aslihantaskiran@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-12-07"><day>07</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>12</month><year>2023</year></pub-date><volume>5</volume><issue>6</issue><elocation-id>fcad340</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2023</year></date><date date-type="rev-recd"><day>10</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="fcad340.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" id="RA1" xlink:href="10.1093/braincomms/fcad342"/><counts><page-count count="2"/></counts></article-meta></front><body><p>The World Health Organization declared end to coronavirus disease 2019 (COVID-19) pandemic on May 5, 2023. Certainly, this did not mean that SARS-CoV2 would not be a concern in our daily medical practice. As neurologists, we may even not have seen the major neurological disease burden caused by this virus regarding the long-term sequelae in COVID-19 survivors.</p><p>SARS-CoV2 is a neurotropic virus. Although direct evidence is not present, the virus is thought to enter the neural tissue either hematogenously or through peripheral nerve endings and access the brain via retrograde transport. The neurological symptoms of long COVID may arise from this invasion.<sup><xref rid="fcad340-B1" ref-type="bibr">1</xref></sup></p><p>There was a remarkable research article in <italic toggle="yes">Brain Communications</italic> in June 2023 by Thomasson <italic toggle="yes">et al</italic>. on limbic system damage following SARS-CoV2 infection.<sup><xref rid="fcad340-B2" ref-type="bibr">2</xref></sup> They delicately showed that moderately and severely affected COVID-19 patients displayed impaired emotion recognition which was also associated with decreased memory and olfactory abilities. Moreover, they identified altered functional connectivity patterns involving cortico-subcortical-cerebellar networks at 6&#x02013;9 months post-infection.</p><p>From the very beginning, the limbic system has been under the spotlight since loss of olfaction was one of the major presenting symptoms of SARS-CoV2 infection. Subsequent studies have shown altered metabolism, perfusion, structure or connectivity in the limbic structures after COVID-19.<sup><xref rid="fcad340-B3" ref-type="bibr">3-6</xref></sup> This study adds to these data by showing the behavioural consequences of limbic system damage and associated functional connectivity changes simultaneously, 6&#x02013;9 months after COVID-19. The main question we wonder about at this point is whether there were accompanying structural changes in the limbic sites of the brain. The authors tried to assess this issue by volume-based morphometric analyses. They reported no structural differences in the anatomical images that could be associated with the functional patterns. We would like to point out that the absence of a control group in the study makes it difficult to detect an attributable structural change. Alterations in limbic brain structures were evident even in mild, non-hospitalized patients in previous studies.<sup><xref rid="fcad340-B6" ref-type="bibr">6</xref>,<xref rid="fcad340-B7" ref-type="bibr">7</xref></sup> Both atrophy and increase in thickness of cortical areas have been reported at varying time points after the infection&#x02014;in the acute or subacute period.<sup><xref rid="fcad340-B8" ref-type="bibr">8</xref>,<xref rid="fcad340-B9" ref-type="bibr">9</xref></sup> One of the main concerns relating SARS-CoV2 is secondary neurodegeneration and cerebral cortical atrophy is an important finding with this regard. In the long run, we may encounter function and network impairment without any structural damage (i.e. atrophy). However, if anatomical structure becomes atrophic along with the function and network disruptions, that can imply degenerative process and warrants special consideration. We think it may be useful to include this information in the valuable cohort of Thomasson <italic toggle="yes">et al</italic>. Additionally, Supplementary Table&#x000a0;4 in their article<sup><xref rid="fcad340-B2" ref-type="bibr">2</xref></sup> documents the authors&#x02019; volume-based morphometric findings and we could only see amygdala, but not hippocampus or insula, in the brain parcels of structural analyses. Insulae, hippocampus, parahippocampus, perirhinal and entorhinal cortices are frequently reported to be affected in long COVID.<sup><xref rid="fcad340-B6" ref-type="bibr">6</xref>,<xref rid="fcad340-B7" ref-type="bibr">7</xref>,<xref rid="fcad340-B10" ref-type="bibr">10</xref></sup> A detailed re-evaluation of these structures in the authors&#x02019; sample and comparison with an age- and sex-matched control group may yield important results in terms of neurodegenerative diseases anticipated after the pandemic.</p><p>In conclusion, SARS-CoV2 related neurological issues were not limited to the acute complications or long COVID and such research concerning the neural damage following SARS-CoV2 infection should continue unabated.</p></body><back><sec id="fcad340-s0"><title>Funding</title><p>None.</p></sec><sec sec-type="COI-statement" id="fcad340-s1"><title>Competing interests</title><p>The authors report no competing interests.</p></sec><sec sec-type="data-availability" id="fcad340-s2"><title>Data availability</title><p>Data sharing is not applicable to this article as no new data were created or analysed.</p></sec><ref-list id="ref1"><title>References</title><ref id="fcad340-B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Reza-Zaldivar</surname>
<given-names>EE</given-names>
</string-name>, <string-name><surname>Hernandez-Sapiens</surname><given-names>MA</given-names></string-name>, <string-name><surname>Minjarez</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Infection mechanism of SARS-COV-2 and its implication on the nervous system</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>621735</fpage>.<pub-id pub-id-type="pmid">33584720</pub-id>
</mixed-citation></ref><ref id="fcad340-B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Thomasson</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Voruz</surname><given-names>P</given-names></string-name>, <string-name><surname>Cionca</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Markers of limbic system damage following SARS-CoV-2 infection</article-title>. <source>Brain Commun</source>. <year>2023</year>;<volume>5</volume>(<issue>4</issue>):<fpage>fcad177</fpage>.<pub-id pub-id-type="pmid">37415776</pub-id>
</mixed-citation></ref><ref id="fcad340-B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qin</surname>
<given-names>Y</given-names>
</string-name>, <string-name><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name><surname>Chen</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations</article-title>. <source>J Clin Invest</source>. <year>2021</year>;<volume>131</volume>(<issue>8</issue>).</mixed-citation></ref><ref id="fcad340-B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Du</surname>
<given-names>YY</given-names>
</string-name>, <string-name><surname>Zhao</surname><given-names>W</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>XL</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Survivors of COVID-19 exhibit altered amplitudes of low frequency fluctuation in the brain: A resting-state functional magnetic resonance imaging study at 1-year follow-up</article-title>. <source>Neural Regen Res</source>. <year>2022</year>;<volume>17</volume>(<issue>7</issue>):<fpage>1576</fpage>&#x02013;<lpage>1581</lpage>.<pub-id pub-id-type="pmid">34916443</pub-id>
</mixed-citation></ref><ref id="fcad340-B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sollini</surname>
<given-names>M</given-names>
</string-name>, <string-name><surname>Morbelli</surname><given-names>S</given-names></string-name>, <string-name><surname>Ciccarelli</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Long COVID hallmarks on [18F]FDG-PET/CT: A case-control study</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2021</year>;<volume>48</volume>(<issue>10</issue>):<fpage>3187</fpage>&#x02013;<lpage>3197</lpage>.<pub-id pub-id-type="pmid">33677642</pub-id>
</mixed-citation></ref><ref id="fcad340-B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Douaud</surname>
<given-names>G</given-names>
</string-name>, <string-name><surname>Lee</surname><given-names>S</given-names></string-name>, <string-name><surname>Alfaro-Almagro</surname><given-names>F</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>SARS-CoV-2 is associated with changes in brain structure in UK Biobank</article-title>. <source>Nature</source>. <year>2022</year>;<volume>604</volume>(<issue>7907</issue>):<fpage>697</fpage>&#x02013;<lpage>707</lpage>.<pub-id pub-id-type="pmid">35255491</pub-id>
</mixed-citation></ref><ref id="fcad340-B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Taskiran-Sag</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Kizil</surname><given-names>PG</given-names></string-name>, <string-name><surname>Yuce</surname><given-names>D</given-names></string-name>, <string-name><surname>Eroglu</surname><given-names>E</given-names></string-name></person-group>. <article-title>Grey matter analysis in non-severe COVID-19 points out limbic-related cortex and substantia nigra</article-title>. <source>Neurol Asia</source>. <year>2023</year>;<volume>28</volume>(<issue>2</issue>):<fpage>307</fpage>&#x02013;<lpage>314</lpage>.</mixed-citation></ref><ref id="fcad340-B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bendella</surname>
<given-names>Z</given-names>
</string-name>, <string-name><surname>Widmann</surname><given-names>CN</given-names></string-name>, <string-name><surname>Layer</surname><given-names>JP</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Brain volume changes after COVID-19 compared to healthy controls by artificial intelligence-based MRI volumetry</article-title>. <source>Diagnostics (Basel)</source>. <year>2023</year>;<volume>13</volume>(<issue>10</issue>):<fpage>1716</fpage>.<pub-id pub-id-type="pmid">37238200</pub-id>
</mixed-citation></ref><ref id="fcad340-B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sanabria-Diaz</surname>
<given-names>G</given-names>
</string-name>, <string-name><surname>Etter</surname><given-names>MM</given-names></string-name>, <string-name><surname>Melie-Garcia</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Brain cortical alterations in COVID-19 patients with neurological symptoms</article-title>. <source>Front Neurosci</source>. <year>2022</year>;<volume>16</volume>:<fpage>992165</fpage>.<pub-id pub-id-type="pmid">36340780</pub-id>
</mixed-citation></ref><ref id="fcad340-B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Besteher</surname>
<given-names>B</given-names>
</string-name>, <string-name><surname>Machnik</surname><given-names>M</given-names></string-name>, <string-name><surname>Troll</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Larger gray matter volumes in neuropsychiatric long-COVID syndrome</article-title>. <source>Psychiatry Res</source>. <year>2022</year>;<volume>317</volume>:<fpage>114836</fpage>.<pub-id pub-id-type="pmid">36087363</pub-id>
</mixed-citation></ref></ref-list></back></article>
